Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Enrollment complete for hepatitis C vaccine phase I trial

Feb. 19, 1998

Endorex licenses oral hepatitis B vaccine technology

Feb. 19, 1998

Bio-Technology General licenses hepatitis B vaccine

Feb. 17, 1998

JB-9315: a new H2 antagonist with both antisecretory and cytoprotective properties

Feb. 16, 1998

Plant extract DA-9601 protects against NSAID-induced gastric damage

Feb. 12, 1998

New agents for IBS from Nippon Shinyaku

Feb. 11, 1998

Maxamine/Infergen combination to be tested in clinic

Feb. 9, 1998

EMEA decision on Zacutex MAA deferred

Feb. 9, 1998

Schering-Plough discloses HCV NS3 protease inhibitors

Feb. 9, 1998

K+ channel blockers patented by HMR for ulcers, arrhythmias

Feb. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...